Testing effectiveness (Phase 2)Study completedNCT00585013
What this trial is testing
Inhaled NO as an Anti-inflammatory and Anti-reperfusion Agent in Infants and Children Undergoing Cardiopulmonary Bypass
Who this might be right for
Congenital Heart Disease
Washington University School of Medicine 17